-
1
-
-
0022495870
-
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
-
Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
-
(1986)
J. Virol.
, vol.59
, pp. 284-291
-
-
Adachi, A.1
Gendelman, H.E.2
Koenig, S.3
Folks, T.4
Willey, R.5
Rabson, A.6
Martin, M.A.7
-
2
-
-
0026473874
-
Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells
-
Akari, H., J. Sakuragi, Y. Takebe, K. Tomonaga, M. Kawamura, M. Fukasawa, T. Miura, T. Shinjo, and M. Hayami. 1992. Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells. Arch. Virol. 123:157-167.
-
(1992)
Arch. Virol.
, vol.123
, pp. 157-167
-
-
Akari, H.1
Sakuragi, J.2
Takebe, Y.3
Tomonaga, K.4
Kawamura, M.5
Fukasawa, M.6
Miura, T.7
Shinjo, T.8
Hayami, M.9
-
3
-
-
0032743236
-
Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: Functional difference between Vif and Nef
-
Akari, H., T. Uchiyama, T. Fukumori, S. Iida, A. H. Koyama, and A. Adachi. 1999. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: Functional difference between Vif and Nef. J. Gen. Virol. 80:2945-2949.
-
(1999)
J. Gen. Virol.
, vol.80
, pp. 2945-2949
-
-
Akari, H.1
Uchiyama, T.2
Fukumori, T.3
Iida, S.4
Koyama, A.H.5
Adachi, A.6
-
4
-
-
0026592529
-
Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type 1, and other retroviruses
-
Bess, J. W., Jr., P. J. Powell, H. J. Issaq, L. J. Schumack, M. K. Grimes, L. E. Henderson, and L. O. Arthur. 1992. Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type 1, and other retroviruses. J. Virol. 66:840-847.
-
(1992)
J. Virol.
, vol.66
, pp. 840-847
-
-
Bess J.W., Jr.1
Powell, P.J.2
Issaq, H.J.3
Schumack, L.J.4
Grimes, M.K.5
Henderson, L.E.6
Arthur, L.O.7
-
5
-
-
0027198765
-
Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle
-
Blanc, D., C. Patience, T. F. Schulz, R. Weiss, and B. Spire. 1993. Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle. Virology 193:186-192.
-
(1993)
Virology
, vol.193
, pp. 186-192
-
-
Blanc, D.1
Patience, C.2
Schulz, T.F.3
Weiss, R.4
Spire, B.5
-
6
-
-
0028915063
-
Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity
-
Borman, A. M., C. Quillent, P. Charneau, C. Dauguet, and F. Clavel. 1995. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity. J. Virol. 69:2058-2067.
-
(1995)
J. Virol.
, vol.69
, pp. 2058-2067
-
-
Borman, A.M.1
Quillent, C.2
Charneau, P.3
Dauguet, C.4
Clavel, F.5
-
7
-
-
0030812551
-
Gag precursor
-
Gag precursor. J. Virol. 71:9358-9365.
-
(1997)
J. Virol.
, vol.71
, pp. 9358-9365
-
-
Bouyac, M.1
Courcoul, M.2
Bertoia, G.3
Baudat, Y.4
Gabuzda, D.5
Blanc, D.6
Chazal, N.7
Boulanger, P.8
Sire, J.9
Vigne, R.10
Spire, B.11
-
8
-
-
0031041175
-
Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells
-
Bouyac, M., F. Rey, M. Nascimbeni, M. Courcoul, J. Sire, D. Blanc, F. Clavel, R. Vigne, and B. Spire. 1997. Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J. Virol. 71:2473-2477.
-
(1997)
J. Virol.
, vol.71
, pp. 2473-2477
-
-
Bouyac, M.1
Rey, F.2
Nascimbeni, M.3
Courcoul, M.4
Sire, J.5
Blanc, D.6
Clavel, F.7
Vigne, R.8
Spire, B.9
-
9
-
-
0028325203
-
Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency
-
Butera, S. T., B. D. Roberts, L. Lam, T. Hodge, and T. M. Folks. 1994. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. J. Virol. 68:2726-2730.
-
(1994)
J. Virol.
, vol.68
, pp. 2726-2730
-
-
Butera, S.T.1
Roberts, B.D.2
Lam, L.3
Hodge, T.4
Folks, T.M.5
-
10
-
-
0029821868
-
Characterization of human immunodeficiency virus type 1 Vif particle incorporation
-
Camaur, D., and D. Trono. 1996. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol. 70:6106-6111.
-
(1996)
J. Virol.
, vol.70
, pp. 6106-6111
-
-
Camaur, D.1
Trono, D.2
-
11
-
-
0034050992
-
Feline immunodeficiency virus Vif localizes to the nucleus
-
Chatterji, U., C. K. Grant, and J. H. Elder. 2000. Feline immunodeficiency virus Vif localizes to the nucleus. J. Virol. 74:2533-2540.
-
(2000)
J. Virol.
, vol.74
, pp. 2533-2540
-
-
Chatterji, U.1
Grant, C.K.2
Elder, J.H.3
-
12
-
-
0036091692
-
Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus
-
Chertova, E., J. W. Bess, Jr., B. J. Crise, R. C. Sowder II, T. M. Schaden, J. M. Hilburn, J. A. Hoxie, R. E. Benveniste, J. D. Lifson, L. E. Henderson, and L. O. Arthur. 2002. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol. 76:5315-5325.
-
(2002)
J. Virol.
, vol.76
, pp. 5315-5325
-
-
Chertova, E.1
Bess J.W., Jr.2
Crise, B.J.3
Sowder R.C. II4
Schaden, T.M.5
Hilburn, J.M.6
Hoxie, J.A.7
Benveniste, R.E.8
Lifson, J.D.9
Henderson, L.E.10
Arthur, L.O.11
-
13
-
-
0030015293
-
vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus
-
Chowdhury, I. H., W. Chao, M. J. Potash, P. Sova, H. E. Gendelman, and D. J. Volsky. 1996. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. J. Virol. 70:5336-5345.
-
(1996)
J. Virol.
, vol.70
, pp. 5336-5345
-
-
Chowdhury, I.H.1
Chao, W.2
Potash, M.J.3
Sova, P.4
Gendelman, H.E.5
Volsky, D.J.6
-
14
-
-
0024509396
-
Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone
-
Clouse, K. A., D. Powell, I. Washington, G. Poli, K. Strebel, W. Farrar, P. Barstad, J. Kovacs, A. S. Fauci, and T. M. Folks. 1989. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J. Immunol. 142:431-438.
-
(1989)
J. Immunol.
, vol.142
, pp. 431-438
-
-
Clouse, K.A.1
Powell, D.2
Washington, I.3
Poli, G.4
Strebel, K.5
Farrar, W.6
Barstad, P.7
Kovacs, J.8
Fauci, A.S.9
Folks, T.M.10
-
15
-
-
0028926644
-
Peripheral blood mononuclear cells produce normal amounts of defective Vif-human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps
-
Courcoul, M., C. Patience, F. Rey, D. Blanc, A. Harmache, J. Sire, R. Vigne, and B. Spire. 1995. Peripheral blood mononuclear cells produce normal amounts of defective Vif-human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J. Virol. 69:2068-2074.
-
(1995)
J. Virol.
, vol.69
, pp. 2068-2074
-
-
Courcoul, M.1
Patience, C.2
Rey, F.3
Blanc, D.4
Harmache, A.5
Sire, J.6
Vigne, R.7
Spire, B.8
-
16
-
-
0033798414
-
Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription
-
Dettenhofer, M., S. Cen, B. A. Carlson, L. Kleiman, and X. F. Yu. 2000. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription. J. Virol. 74:8938-8945.
-
(2000)
J. Virol.
, vol.74
, pp. 8938-8945
-
-
Dettenhofer, M.1
Cen, S.2
Carlson, B.A.3
Kleiman, L.4
Yu, X.F.5
-
17
-
-
0032935035
-
Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions
-
Dettenhofer, M., and X. F. Yu. 1999. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 73:1460-1467.
-
(1999)
J. Virol.
, vol.73
, pp. 1460-1467
-
-
Dettenhofer, M.1
Yu, X.F.2
-
18
-
-
0034089206
-
Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription
-
Dornadula, G., S. Yang, R. J. Pomerantz, and H. Zhang. 2000. Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription. J. Virol. 74:2594-2602.
-
(2000)
J. Virol.
, vol.74
, pp. 2594-2602
-
-
Dornadula, G.1
Yang, S.2
Pomerantz, R.J.3
Zhang, H.4
-
19
-
-
0026786712
-
Cell-free transmission of Vif mutants of HIV-1
-
Fan, L., and K. Peden. 1992. Cell-free transmission of Vif mutants of HIV-1. Virology 190:19-29.
-
(1992)
Virology
, vol.190
, pp. 19-29
-
-
Fan, L.1
Peden, K.2
-
20
-
-
0023191658
-
The sor gene of HIV-1 is required for efficient virus transmission in vitro
-
Fisher, A. G., B. Ensoli, L. Ivanoff, M. Chamberlain, S. Petteway, L. Ratner, R. C. Gallo, and F. Wong-Staal. 1987. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237:888-893.
-
(1987)
Science
, vol.237
, pp. 888-893
-
-
Fisher, A.G.1
Ensoli, B.2
Ivanoff, L.3
Chamberlain, M.4
Petteway, S.5
Ratner, L.6
Gallo, R.C.7
Wong-Staal, F.8
-
21
-
-
0030747461
-
HIV-1 infection of non-dividing cells: Evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import
-
Fouchier, R. A., B. E. Meyer, J. H. Simon, U. Fischer, and M. H. Malim. 1997. HIV-1 infection of non-dividing cells: Evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16:4531-4539.
-
(1997)
EMBO J.
, vol.16
, pp. 4531-4539
-
-
Fouchier, R.A.1
Meyer, B.E.2
Simon, J.H.3
Fischer, U.4
Malim, M.H.5
-
22
-
-
0029961360
-
Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins
-
Fouchier, R. A., J. H. Simon, A. B. Jaffe, and M. H. Malim. 1996. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J. Virol. 70:8263-8269.
-
(1996)
J. Virol.
, vol.70
, pp. 8263-8269
-
-
Fouchier, R.A.1
Simon, J.H.2
Jaffe, A.B.3
Malim, M.H.4
-
24
-
-
0027953516
-
Subcellular localization of the Vif protein of human immunodeficiency virus type 1
-
Goncalves, J., P. Jallepalli, and D. H. Gabuzda. 1994. Subcellular localization of the Vif protein of human immunodeficiency virus type 1. J. Virol. 68:704-712.
-
(1994)
J. Virol.
, vol.68
, pp. 704-712
-
-
Goncalves, J.1
Jallepalli, P.2
Gabuzda, D.H.3
-
25
-
-
0029861076
-
Role of Vif in human immunodeficiency virus type 1 reverse transcription
-
Goncalves, J., Y. Korin, J. Zack, and D. Gabuzda. 1996. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol. 70:8701-8709.
-
(1996)
J. Virol.
, vol.70
, pp. 8701-8709
-
-
Goncalves, J.1
Korin, Y.2
Zack, J.3
Gabuzda, D.4
-
26
-
-
0028871720
-
Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains
-
Goncalves, J., B. Shi, X. Yang, and D. Gabuzda. 1995. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains. J. Virol. 69:7196-7204.
-
(1995)
J. Virol.
, vol.69
, pp. 7196-7204
-
-
Goncalves, J.1
Shi, B.2
Yang, X.3
Gabuzda, D.4
-
27
-
-
0035116505
-
Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure
-
Henzler, T., A. Harmache, H. Herrmann, H. Spring, M. Suzan, G. Audoly, T. Panek, and V. Bosch. 2001. Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure. J. Gen. Virol. 82:561-573.
-
(2001)
J. Gen. Virol.
, vol.82
, pp. 561-573
-
-
Henzler, T.1
Harmache, A.2
Herrmann, H.3
Spring, H.4
Suzan, M.5
Audoly, G.6
Panek, T.7
Bosch, V.8
-
28
-
-
0028200823
-
Role of vif during packing of the core of HIV-1
-
Hoglund, S., A. Ohagen, K. Lawrence, and D. Gabuzda. 1994. Role of vif during packing of the core of HIV-1. Virology 201:349-355.
-
(1994)
Virology
, vol.201
, pp. 349-355
-
-
Hoglund, S.1
Ohagen, A.2
Lawrence, K.3
Gabuzda, D.4
-
29
-
-
15644378119
-
Interaction and coencapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins
-
Huvent, I., S. S. Hong, C. Fournier, B. Gay, J. Tournier, C. Carriere, M. Courcoul, R. Vigne, B. Spire, and P. Boulanger. 1998. Interaction and coencapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins. J. Gen. Virol. 79:1069-1081.
-
(1998)
J. Gen. Virol.
, vol.79
, pp. 1069-1081
-
-
Huvent, I.1
Hong, S.S.2
Fournier, C.3
Gay, B.4
Tournier, J.5
Carriere, C.6
Courcoul, M.7
Vigne, R.8
Spire, B.9
Boulanger, P.10
-
30
-
-
0029655893
-
Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein
-
Karczewski, M. K., and K. Strebel. 1996. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J. Virol. 70:494-507.
-
(1996)
J. Virol.
, vol.70
, pp. 494-507
-
-
Karczewski, M.K.1
Strebel, K.2
-
31
-
-
0034899286
-
Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA
-
Khan, M. A., C. Aberham, S. Kao, H. Akari, R. Gorelick, S. Bour, and K. Strebel. 2001. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA. J. Virol. 75:7252-7265.
-
(2001)
J. Virol.
, vol.75
, pp. 7252-7265
-
-
Khan, M.A.1
Aberham, C.2
Kao, S.3
Akari, H.4
Gorelick, R.5
Bour, S.6
Strebel, K.7
-
32
-
-
0036720794
-
Intravirion processing of human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function
-
Khan, M. A., H. Akari, S. Kao, C. Aberham, D. Davis, A. Buckler-White, and K. Strebel. 2002. Intravirion processing of human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function. J. Virol. 76:9112-9123.
-
(2002)
J. Virol.
, vol.76
, pp. 9112-9123
-
-
Khan, M.A.1
Akari, H.2
Kao, S.3
Aberham, C.4
Davis, D.5
Buckler-White, A.6
Strebel, K.7
-
33
-
-
0026558772
-
Cells surviving infection by human immunodeficiency virus type 1: Vif or vpu mutants produce non-infectious or markedly less cytopathic viruses
-
Kishi, M., Y. Nishino, M. Sumiya, K. Ohki, T. Kimura, T. Goto, M. Nakai, M. Kakinuma, and K. Ikuta. 1992. Cells surviving infection by human immunodeficiency virus type 1: Vif or vpu mutants produce non-infectious or markedly less cytopathic viruses. J. Gen. Virol. 73:77-87.
-
(1992)
J. Gen. Virol.
, vol.73
, pp. 77-87
-
-
Kishi, M.1
Nishino, Y.2
Sumiya, M.3
Ohki, K.4
Kimura, T.5
Goto, T.6
Nakai, M.7
Kakinuma, M.8
Ikuta, K.9
-
34
-
-
0028805216
-
The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures
-
Liu, H., X. Wu, M. Newman, G. M. Shaw, B. H. Hahn, and J. C. Kappes. 1995. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 69:7630-7638.
-
(1995)
J. Virol.
, vol.69
, pp. 7630-7638
-
-
Liu, H.1
Wu, X.2
Newman, M.3
Shaw, G.M.4
Hahn, B.H.5
Kappes, J.C.6
-
35
-
-
0031797865
-
An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
-
Madani, N., and D. Kabat. 1998. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72:10251-10255.
-
(1998)
J. Virol.
, vol.72
, pp. 10251-10255
-
-
Madani, N.1
Kabat, D.2
-
36
-
-
0027451949
-
The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2
-
Michaels, F. H., N. Hattori, R. C. Gallo, and G. Franchini. 1993. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. AIDS Res. Hum. Retrovir. 9:1025-1030.
-
(1993)
AIDS Res. Hum. Retrovir.
, vol.9
, pp. 1025-1030
-
-
Michaels, F.H.1
Hattori, N.2
Gallo, R.C.3
Franchini, G.4
-
37
-
-
0031869455
-
The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis
-
Nascimbeni, M., M. Bouyac, F. Rey, B. Spire, and F. Clavel. 1998. The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis. J. Gen. Virol. 79:1945-1950.
-
(1998)
J. Gen. Virol.
, vol.79
, pp. 1945-1950
-
-
Nascimbeni, M.1
Bouyac, M.2
Rey, F.3
Spire, B.4
Clavel, F.5
-
38
-
-
0031044783
-
Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1
-
Ochsenbauer, C., T. Wilk, and V. Bosch. 1997. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1. J. Gen. Virol. 78:627-635.
-
(1997)
J. Gen. Virol.
, vol.78
, pp. 627-635
-
-
Ochsenbauer, C.1
Wilk, T.2
Bosch, V.3
-
39
-
-
0034467080
-
Role of Vif in stability of the human immunodeficiency virus type 1 core
-
Ohagen, A., and D. Gabuzda. 2000. Role of Vif in stability of the human immunodeficiency virus type 1 core. J. Virol. 74:11055-11066.
-
(2000)
J. Virol.
, vol.74
, pp. 11055-11066
-
-
Ohagen, A.1
Gabuzda, D.2
-
40
-
-
0029040506
-
Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants
-
Reddy, T. R., G. Kraus, O. Yamada, D. J. Looney, M. Suhasini, and F. Wong-Staal. 1995. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants. J. Virol. 69:3549-3553.
-
(1995)
J. Virol.
, vol.69
, pp. 3549-3553
-
-
Reddy, T.R.1
Kraus, G.2
Yamada, O.3
Looney, D.J.4
Suhasini, M.5
Wong-Staal, F.6
-
41
-
-
0034255169
-
LuSIV cells: A reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication
-
Roos, J. W., M. F. Maughan, Z. Liao, J. E. Hildreth, and J. E. Clements. 2000. LuSIV cells: A reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication. Virology 273:307-315.
-
(2000)
Virology
, vol.273
, pp. 307-315
-
-
Roos, J.W.1
Maughan, M.F.2
Liao, Z.3
Hildreth, J.E.4
Clements, J.E.5
-
42
-
-
0027447213
-
Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles
-
Sakai, H., R. Shibata, J. Sakuragi, S. Sakuragi, M. Kawamura, and A. Adachi. 1993. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67:1663-1666.
-
(1993)
J. Virol.
, vol.67
, pp. 1663-1666
-
-
Sakai, H.1
Shibata, R.2
Sakuragi, J.3
Sakuragi, S.4
Kawamura, M.5
Adachi, A.6
-
43
-
-
0025766073
-
Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing
-
Schwartz, S., B. K. Felber, and G. N. Pavlakis. 1991. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing. Virology 183:677-686.
-
(1991)
Virology
, vol.183
, pp. 677-686
-
-
Schwartz, S.1
Felber, B.K.2
Pavlakis, G.N.3
-
44
-
-
0037043699
-
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
-
Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
-
(2002)
Nature
, vol.418
, pp. 646-650
-
-
Sheehy, A.M.1
Gaddis, N.C.2
Choi, J.D.3
Malim, M.H.4
-
45
-
-
0029056704
-
Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes
-
Simm, M., M. Shahabuddin, W. Chao, J. S. Allan, and D. J. Volsky. 1995. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J. Virol. 69:4582-4586.
-
(1995)
J. Virol.
, vol.69
, pp. 4582-4586
-
-
Simm, M.1
Shahabuddin, M.2
Chao, W.3
Allan, J.S.4
Volsky, D.J.5
-
46
-
-
0030985926
-
The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells
-
Simon, J. H., R. A. Fouchier, T. E. Southerling, C. B. Guerra, C. K. Grant, and M. H. Malim. 1997. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J. Virol. 71:5259-5267.
-
(1997)
J. Virol.
, vol.71
, pp. 5259-5267
-
-
Simon, J.H.1
Fouchier, R.A.2
Southerling, T.E.3
Guerra, C.B.4
Grant, C.K.5
Malim, M.H.6
-
47
-
-
0031788565
-
Evidence for a newly discovered cellular anti-HIV-1 phenotype
-
Simon, J. H., N. C. Gaddis, R. A. Fouchier, and M. H. Malim. 1998. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4:1397-1400.
-
(1998)
Nat. Med.
, vol.4
, pp. 1397-1400
-
-
Simon, J.H.1
Gaddis, N.C.2
Fouchier, R.A.3
Malim, M.H.4
-
48
-
-
0029956256
-
The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes
-
Simon, J. H., and M. H. Malim. 1996. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol. 70:5297-5305.
-
(1996)
J. Virol.
, vol.70
, pp. 5297-5305
-
-
Simon, J.H.1
Malim, M.H.2
-
49
-
-
0032169163
-
Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function
-
Simon, J. H., D. L. Miller, R. A. Fouchier, and M. H. Malim. 1998. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function. Virology 248:182-187.
-
(1998)
Virology
, vol.248
, pp. 182-187
-
-
Simon, J.H.1
Miller, D.L.2
Fouchier, R.A.3
Malim, M.H.4
-
50
-
-
0029059339
-
Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes
-
Simon, J. H., T. E. Southerling, J. C. Peterson, B. E. Meyer, and M. H. Malim. 1995. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J. Virol. 69:4166-4172.
-
(1995)
J. Virol.
, vol.69
, pp. 4166-4172
-
-
Simon, J.H.1
Southerling, T.E.2
Peterson, J.C.3
Meyer, B.E.4
Malim, M.H.5
-
51
-
-
0033052695
-
Gag polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes
-
Gag polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes. J. Virol. 73:2667-2674.
-
(1999)
J. Virol.
, vol.73
, pp. 2667-2674
-
-
Simon, J.H.M.1
Carpenter, E.A.2
Fouchier, R.A.M.3
Malim, M.H.4
-
52
-
-
0031576533
-
The redox state of cysteines in human immunodeficiency virus type 1 Vif in infected cells and in virions
-
Sova, P., W. Chao, and D. J. Volsky. 1997. The redox state of cysteines in human immunodeficiency virus type 1 Vif in infected cells and in virions. Biochem. Biophys. Res. Commun. 240:257-260.
-
(1997)
Biochem. Biophys. Res. Commun.
, vol.240
, pp. 257-260
-
-
Sova, P.1
Chao, W.2
Volsky, D.J.3
-
53
-
-
0027183349
-
Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1
-
Sova, P., and D. J. Volsky. 1993. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J. Virol. 67:6322-6326.
-
(1993)
J. Virol.
, vol.67
, pp. 6322-6326
-
-
Sova, P.1
Volsky, D.J.2
-
54
-
-
0023267788
-
The HIV 'A' (sor) gene product is essential for virus infectivity
-
Strebel, K., D. Daugherty, K. Clouse, D. Cohen, T. Folks, and M. A. Martin. 1987. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328:728-730.
-
(1987)
Nature
, vol.328
, pp. 728-730
-
-
Strebel, K.1
Daugherty, D.2
Clouse, K.3
Cohen, D.4
Folks, T.5
Martin, M.A.6
-
55
-
-
0027179103
-
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
-
von Schwedler, U., J. Song, C. Aiken, and D. Trono. 1993. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:4945-4955.
-
(1993)
J. Virol.
, vol.67
, pp. 4945-4955
-
-
Von Schwedler, U.1
Song, J.2
Aiken, C.3
Trono, D.4
-
56
-
-
0035895896
-
The multimerization of human immunodeficiency virus type 1 Vif protein: A requirement for Vif function in the viral life cycle
-
Yang, S., Y. Sun, and H. Zhang. 2001. The multimerization of human immunodeficiency virus type 1 Vif protein: A requirement for Vif function in the viral life cycle. J. Biol. Chem. 276:4889-4893.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 4889-4893
-
-
Yang, S.1
Sun, Y.2
Zhang, H.3
-
57
-
-
0028095020
-
A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes
-
Yee, J. K., A. Miyanohara, P. LaPorte, K. Bouic, J. C. Burns, and T. Friedmann. 1994. A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91:9564-9568.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 9564-9568
-
-
Yee, J.K.1
Miyanohara, A.2
LaPorte, P.3
Bouic, K.4
Burns, J.C.5
Friedmann, T.6
-
58
-
-
0033863969
-
Human immunodeficiency virus type 1 Vif protein is an integral component of anmRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process
-
Zhang, H., R. J. Pomerantz, G. Dornadula, and Y. Sun. 2000. Human immunodeficiency virus type 1 Vif protein is an integral component of anmRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process. J. Virol. 74:8252-8261.
-
(2000)
J. Virol.
, vol.74
, pp. 8252-8261
-
-
Zhang, H.1
Pomerantz, R.J.2
Dornadula, G.3
Sun, Y.4
|